248 related articles for article (PubMed ID: 8710741)
21. Effects of citicholine and dimethylsulfoxide on transepithelial transport of passively diffused drugs in the Caco-2 cell culture model.
Demirbas S; Stavchansky S
Int J Pharm; 2003 Jan; 251(1-2):107-12. PubMed ID: 12527180
[TBL] [Abstract][Full Text] [Related]
22. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers.
Sudoh M; Pauletti GM; Yao W; Moser W; Yokoyama A; Pasternak A; Sprengeler PA; Smith AB; Hirschmann R; Borchardt RT
Pharm Res; 1998 May; 15(5):719-25. PubMed ID: 9619780
[TBL] [Abstract][Full Text] [Related]
23. Oleic acid and docosahexaenoic acid cause an increase in the paracellular absorption of hydrophilic compounds in an experimental model of human absorptive enterocytes.
Aspenström-Fagerlund B; Ring L; Aspenström P; Tallkvist J; Ilbäck NG; Glynn AW
Toxicology; 2007 Jul; 237(1-3):12-23. PubMed ID: 17560003
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants.
Jakobsen S; Gaenaelle Gé L; Pedersen M; Griffin BT; Holm R; Uhd Nielsen C
Int J Pharm; 2022 Aug; 624():121885. PubMed ID: 35690306
[TBL] [Abstract][Full Text] [Related]
25. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
26. Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol.
Salama NN; Fasano A; Lu R; Eddington ND
Int J Pharm; 2003 Jan; 251(1-2):113-21. PubMed ID: 12527181
[TBL] [Abstract][Full Text] [Related]
27. Effect of different surfactants in biorelevant medium on the secretion of a lipophilic compound in lipoproteins using Caco-2 cell culture.
Karpf DM; Holm R; Garafalo C; Levy E; Jacobsen J; Müllertz A
J Pharm Sci; 2006 Jan; 95(1):45-55. PubMed ID: 16307455
[TBL] [Abstract][Full Text] [Related]
28. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
Batrakova EV; Li S; Miller DW; Kabanov AV
Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
[TBL] [Abstract][Full Text] [Related]
29. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport.
Leonard M; Creed E; Brayden D; Baird AW
Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222
[TBL] [Abstract][Full Text] [Related]
31. Change in tolbutamide permeability in rat jejunum and Caco-2 cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional medicine.
Nishimura N; Uemura T; Iwamoto K; Naora K
J Pharm Pharmacol; 2010 May; 62(5):651-7. PubMed ID: 20609069
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers.
Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066
[TBL] [Abstract][Full Text] [Related]
33. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
34. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
Kotzé AF; Luessen HL; de Boer AG; Verhoef JC; Junginger HE
Eur J Pharm Sci; 1999 Jan; 7(2):145-51. PubMed ID: 9845799
[TBL] [Abstract][Full Text] [Related]
35. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.
Weinheimer M; Fricker G; Burhenne J; Mylius P; Schubert R
Eur J Pharm Sci; 2017 Oct; 108():13-22. PubMed ID: 27590127
[TBL] [Abstract][Full Text] [Related]
36. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
37. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
[TBL] [Abstract][Full Text] [Related]
38. Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.
Udata C; Patel J; Pal D; Hejchman E; Cushman M; Mitra AK
Int J Pharm; 2003 Jan; 250(1):157-68. PubMed ID: 12480282
[TBL] [Abstract][Full Text] [Related]
39. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells.
Batrakova EV; Han HY; Miller DW; Kabanov AV
Pharm Res; 1998 Oct; 15(10):1525-32. PubMed ID: 9794493
[TBL] [Abstract][Full Text] [Related]
40. Physiological and cytotoxic effects of Ca(2+) ionophores on Caco-2 paracellular permeability: relationship of 45Ca(2+) efflux to 51 Cr release.
Rutten MJ; Cogburn JN; Schasteen CS; Solomon T
Pharmacology; 1991; 42(3):156-68. PubMed ID: 1905412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
